Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis

Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis

Lu Diao,1,2 Jin Tao,2 Yiqi Wang,3 Ying Hu,1,2 Wenfei He1 1School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of China; 2College of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, Zhejiang 315100, People’s Republic of Chin...

Full description

Bibliographic Details
Main Authors: Diao L, Tao J, Wang Y, Hu Y, He W
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:International Journal of Nanomedicine
Subjects:
cationic liposome
hmgb1 sirna
dha
toll-like receptor 4
Online Access:https://www.dovepress.com/co-delivery-of-dihydroartemisinin-and-hmgb1-sirna-by-tat-modified-cati-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/co-delivery-of-dihydroartemisinin-and-hmgb1-sirna-by-tat-modified-cati-peer-reviewed-article-IJN

Similar Items